Can tumour response predict a survival benefit?

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1249, 2000-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

On-treatment apolipoprotein levels: predictive benefit?

By  

Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Aspirin dosage critical to clinical benefit?

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Do Changes in Selfishness Explain 12-Step Benefit? A Prospective Lagged Analysis

By Tonigan J. Scott   Rynes Kristina   Toscova Radka   Hagler Kylee  

Substance Abuse, Vol. 34, Iss. 1, 2013-01 ,pp. : 13-19

Routledge Ltd

Access to resources Recommend Favorite

Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease: Is There a Clinical Benefit?

By Man S.F. Paul   Sin Don D.  

Drugs, Vol. 65, Iss. 5, 2005-01 ,pp. : 579-591

Adis International

Access to resources Recommend Favorite

Anticoagulation for Stroke Prevention: High Effectiveness, More Cost Benefit?

By Shantsila Eduard   Watson Timothy   Lip Gregory Y.H.  

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 1035-1038

Adis International

Access to resources Recommend Favorite